Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 17, 2016

View Archived Issues

Proteostasis Therapeutics announces pricing of initial public offering

NF-kappaB inhibition reduces symptoms in mouse model of Rett syndrome

FKBP5 found to be involved in chronic pain in mouse models

Novartis patents antibacterial quinolone derivatives

Nanjing Sanhome reports compounds for the treatment of HCV infections

Ocular Therapeutix outlines phase III development plans for OTX-TP

Zilretta meets primary endpoint in pivotal phase III trial in patients with knee osteoarthritis

Gabra-3 overexpression increases breast cancer metastasis

Beta cells encapsulated in optimized alginate maintain normoglycemia in mouse model of diabetes

Galapagos initiates phase II program of GLPG-1837 in cystic fibrosis

FDA grants breakthrough therapy designation for durvalumab

Remedy Pharmaceuticals' Cirara obtains two FDA orphan designations

Phase II study of TNX-201 misses primary endpoints

Biota Pharmaceuticals' BTA-585 granted FDA fast track designation

Kevetrin demonstrates safety and tolerability in phase I study in solid tumors

Apogenix receives grant for immuno-oncology candidate and companion diagnostic

Lipocine reports topline results from study of LPCN-1107

Zepatier available in U.S.

Eisai and Sysmex to codevelop dementia diagnostics

Sernova receives initial funds for development of severe hemophilia A therapy

Carmot Therapeutics and Amgen extend research collaboration

BIND and Synergy to collaborate on Accurin research

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...